Mylan N.V. (NASDAQ, TASE: MYL), today announced the U.S. launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, 18 mg, 27 mg, 36 mg and 54 mg, a generic version of Janssen's Concerta® ...
The MarketWatch News Department was not involved in the creation of this content. ALPHARETTA, Ga., Aug. 19, 2025 /PRNewswire/ -- Alora Pharmaceuticals, LLC, the parent company of Vertical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results